ArticleBioscience reports2020

Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy.

Anas Shamsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.